Background Dendritic cells (DCs) are potent antigenpresenting cells that are central to the regulation, maturation, and maintenance of the cellular immune response against cancer. In contrast, CD4
Introduction
Dendritic cells (DCs), as professional antigen-presenting cells (APCs), play an important role in the antitumor immune response. DCs take up tumor-associated antigen in tumor tissue and migrate to regional lymph nodes to generate cytotoxic T cells. The antigen/pathogen induces the immature DCs to undergo phenotypic and functional changes that culminate in the complete transition from antigencapturing cells to APCs. DC maturation is intimately linked with their migration from the peripheral tissue to the draining lymphoid organs [1] . CD83 is a 45-kDa transmembranous protein and member of the immunoglobulin super family [2] , and is expressed by mature DCs, but not by B cells, natural killer (NK) cells, or monocytes [3] , and can be a useful marker of mature DCs [4] [5] [6] . Previous studies have shown that a low density of CD83
? DCs in various cancer tissues is associated with poor prognosis [7] [8] [9] [10] [11] [12] . However, regarding DC activation, it is not clear what kind of immune responses occur in the draining lymph nodes.
In contrast to the activation of immune responses initiated by DCs, the immune response in tumors is suppressed by CD4
? CD25 ? regulatory cells (Tregs) [13] [14] [15] [16] , which play an important role in immunological self-tolerance [17, 18] . Tregs have also been shown to contribute to cancerrelated immunosuppression [19, 20] . Recently, it has been reported that Foxp3, forkhead/winged helix transcription factor, is a reliable marker of Tregs [21] [22] [23] , and immunostaining using specific antibody makes it possible to define Tregs more strictly as CD4
? CD25 ? Foxp3 ? cells.
Increased density of Foxp3
? Tregs in cancer tissue has been seen in various cancers, including lung, liver, pancreas, ovary, and head and neck [24] [25] [26] [27] [28] . In a recent study, Mizukami et al. [29] reported that the localization pattern of Tregs was associated with clinical behavior in gastric cancer. The density of Foxp3
? Tregs in relation to prognosis remain controversial, and there is a question whether infiltrating Tregs, in particular Foxp3
? Tregs, are related to clinical outcome [30] .
In this study, we focused on the density of CD83 ? DCs and Foxp3
? Tregs in primary tumors and regional lymph nodes, from the viewpoint of two opposing factors in immune responses. We showed that the density of each cell type was inversely correlated with tumor progression and metastasis in the prognosis of patients with gastric cancer.
Patients, materials, and methods

Patients
We enrolled 123 patients (89 men, 34 women; age range 18-86 years, mean 66.9 years), who had undergone gastrectomy in the Fukushima Medical University Hospital between January 2000 and December 2004, and who had histologically proven gastric carcinoma. The follow-up period was from 2000 to 2009. Tumor characteristics were determined according to the Japanese classification of gastric carcinoma (JCGC) [31] and are listed in Table 1 . The depth of tumor invasion (T category) and extent of lymph node metastasis (N category) were determined by histological diagnosis. There were 62 T1 tumors, 32 T2, 23 T3, and six T4. Lymph nodes were involved in 42 patients (N1 in 23, N2 in 12, and N3 in seven). Consequently, tumor stage was determined as IA in 55 patients, IB in 25, II in 10, IIIA in nine, IIIB in four, and IV in 20. Forty-two patients were lymph node-positive. The positive and negative lymph nodes were examined in 40 patients after excluding two that had all positive lymph nodes. In the 40 lymph-node-negative patients, regional lymph nodes were also examined. Patients with other malignant lesions upon preoperative clinical diagnosis were excluded from the examination. In addition, normal gastric tissue from 30 patients with early gastric cancer, taken far from the cancerous lesion in the same section, was used as a control.
Outcomes in patients with gastric cancer
Relapses occurred in 10 patients who had received curative surgery, because of the recurrence of peritoneal metastasis (n = 6), hepatic metastasis (n = 3), and lymph node metastasis (n = 1). Causes of death in the patients, including those with non-curative operations, were peritoneal metastasis (n = 9), hepatic metastasis (n = 5), and other diseases (n = 10). Patients who underwent noncurative surgery received postoperative chemotherapy using S-1, cisplatin, paclitaxel, or irinotecan, according to the choice of the physician.
Immunohistochemistry
Immunohistochemical reactions were performed using the streptavidin-biotin-peroxidase method. Anti-mouse CD83 monoclonal antibody (mAb) (clone HB15a; Santa Cruz Biotechnology, Heidelberg, Germany) and anti-mouse Foxp3 mAb (clone 236A/E7; Abcam, Cambridge, UK) were used. Tissue specimens including the deepest lesions of the primary tumor and lymph nodes were fixed in 10% neutral buffered formalin and embedded in paraffin. Sections were cut at 4-lm thicknesses, deparaffinized, and rehydrated. After the blocking of endogenous peroxidase with methanol containing 0.3% H 2 O 2 , for antigen retrieval, the sections were autoclaved at 121°C for 10 min in citrate buffer (10 mmol/l sodium citrate, pH 6.0) for staining with anti-Foxp3 mAb. The sections were boiled in a microwave oven for 15 min for staining with anti-CD83 mAb. After blocking with normal horse serum for Foxp3 or normal goat serum for CD83, the sections were reacted overnight with appropriately diluted primary antibodies. The sections were reacted sequentially with biotin-conjugated antimouse IgG antibodies (Vector Laboratories, Burlingame, CA, USA) and Vectastain Elite ABC reagent (Vector Laboratories). Immunohistochemical reactions were visualized with freshly prepared 3,3'-diamino-benzidine tetrahydrochloride. Slides were counterstained with hematoxylin and mounted on coverslips.
Quantification methods
Positively stained cells in normal gastric tissue, primary tumors, and lymph nodes were counted with a microscope (Nikon, Tokyo, Japan) at high power (4009) magnification. The tumor status of primary lesions and lymph nodes was determined by hematoxylin and eosin staining. We assessed each slide at the invasive margin of the tumor. We selected group 1 lymph nodes with and without metastasis classified by JCGC, and the normal gastric tissues in the patients with early gastric cancer were selected more than 1 cm away from carcinoma tissues. In each section, the degree of immune cell infiltration was observed in more than 10 independent high-power microscopic fields. The five areas with the most abundant distribution were selected without any previous knowledge of the patients' Prognosis of gastric cancer 145 clinical backgrounds. We determined the total number of DCs and Foxp3 ? Tregs from five areas and then calculated the mean number for analysis of survival. Patients were divided into two groups for each variable, using median values as the cut-off points.
Statistical analysis
Statistical analysis was performed using StatView V.5.0 software (SAS Institute, Cary, NC, USA). Associations among the variables were assessed by the Mann-Whitney U-test and Kruskal-Wallis test. Survival curves were calculated using the Kaplan-Meier method and compared with the log-rank test. Both univariate and multivariate analyses of immune cell infiltration and clinicopathological features were performed using the Cox proportional hazards model. P \ 0.05 was regarded as significant in all analyses.
Results
Immunohistochemical analysis of CD83
? DCs and Foxp3
? Tregs in gastric cancer tissues and lymph nodes
CD83
? DCs and Foxp3 ? Tregs were specifically visualized immunohistochemically and quantified in normal gastric tissues, primary gastric cancers, and lymph nodes with or without metastasis (Fig. 1) 
DCs and Foxp3
? Tregs in the negative lymph nodes of LNM(-) and LNM(?) cases.
Correlation between CD83
? DCs, Foxp3 ? Tregs, and depth of tumor invasion
The density of CD83
? DCs and and that of Foxp3 ? Tregs in the primary lesion were compared at different depths of tumor invasion (Fig. 2c, d Table 2 ). The numbers of CD83
? DCs were significantly lower in patients with histologically undifferentiated-type tumors, positive LNM, hepatic metastasis, peritoneal invasion, positive peritoneal washing cytology, lymphatic vessel invasion, blood vessel invasion, greater depth of invasion, and higher histological stage.
The numbers of Foxp3
? Tregs were significantly higher in patients with positive LNM, peritoneal invasion, lymphatic vessel invasion, blood vessel invasion, greater depth of invasion, and higher histological stage, but there was no significant difference in numbers of Foxp3
? Tregs in relation to histologically undifferentiated tumors, hepatic metastasis, and positive peritoneal washing cytology.
Univariate and multivariate analyses of survival in gastric cancer
We examined our results by univariate and multivariate analyses, using a Cox proportional hazards model. The clinicopathological factors listed in Table 2 were examined for their association with overall survival (OS) and diseasefree survival (DFS) after initial surgery. In primary lesions, low numbers of CD83
? DCs (Table 3a ; OS: p = 0.0122, DFS: p = 0.0016) and high numbers of Foxp3
? Tregs (OS: p = 0.0222, DFS: p = 0.0250) had a negative influence on OS and DFS in the univariate analysis. In negative lymph nodes in LNM(?) cases, low numbers of CD83
? DCs also had a negative influence on OS and DFS in the univariate analysis (Table 3b ; OS: p = 0.0398, DFS: p = 0.0266). In multivariate Cox proportional hazard analysis for clinicopathological variables, the high-CD83
? DC group in primary lesions had a better prognosis than the low-CD83 DCs contributed greatly to both OS and DFS (Fig. 3a, b) . The low-Foxp3
? Tregs group showed significantly better OS than the high-Foxp3
? Tregs group (Fig. 3c) . The lowFoxp3
? Tregs group also showed significantly better DFS than the high-Foxp3
? Tregs group (Fig. 3d) . When the prognostic significance of CD83
? Tregs was compared among four groups according to the respective parameters (CD83 low/high, Foxp3 low/ high), the survival rate in patients with low-CD83/highFoxp3 group was significantly poorer than that in the other three groups (Fig. 3e) . This was also the case with the DFS (Fig. 3f) . These results indicate that each cell type is inversely correlated with tumor progression and metastasis ? Tregs in negative lymph nodes in gastric cancer with LNM was examined, the density of CD83 in non-metastatic lymph nodes was found to be associated with prognosis (Fig. 4) . The high number of infiltrating DCs contributed greatly to both OS and DFS.
Discussion
Two opposing components of immune responses were examined in primary gastric cancer and regional lymph nodes. CD83
? DCs were decreased in proportion to the stage of cancer (i.e., the lower the CD83
? DC density, the higher the stage), and a low density was significantly ? Tregs density, the higher the stage), and a high density was significantly correlated with poor prognosis. The density of CD83
? DCs and Foxp3 ? Tregs in metastatic lymph nodes was similar to that in primary lesions, when compared with that in negative lymph nodes. This is, to the best of our knowledge, the first study to show that two opposing factors in the immune response in primary lesions, as well as in metastatic lymph nodes, were inversely related.
Immature DCs with a protein S100 marker, as well as mature DCs with a CD83 marker, have been shown to be correlated with the prognosis of various cancers [32] [33] [34] [35] [36] . Tsujitani et al. [32] have reported that infiltrating S100-positive DCs do not prevent the spread of tumor invasion but do prevent nodal involvement. In the present study, the high number of infiltrating DCs contributed to both OS and DFS in negative lymph nodes in gastric cancer with LNM.
Tumor-infiltrating DCs exhibit various phenotypes and functions depending on their maturation status. The expression of S100 on DCs is not specific; therefore, we evaluated maturation-specific tissue infiltration of DCs. We found that the density of CD83 ? DCs was significantly decreased in T1 tumors (tumor invasion within the submucosal layer), and it decreased further in relation to tumor progression. The density of CD83 in primary lesions was a highly independent prognostic factor by both univariate and multivariate analyses. These data were consistent with earlier studies.
The density of Foxp3 ? Tregs in gastric cancer was significantly correlated with prognosis in the present study. A significant increase in the density of these cells was found in T1 tumors, and the density of these cells was further increased in relation to tumor progression. Mizukami et al. [29] have reported that the pattern of localization of Foxp3
? Tregs, rather than the population of these cells counted in randomly selected areas, is associated with ? Tregs in primary lesions was divided into four groups: high-CD83/low-Foxp3 (n = 37), high-CD83/high-Foxp3 (n = 30), low-CD83/low-Foxp3 (n = 24), and low-CD83/highFoxp3 group (n = 32). OS and DFS in patients with the low-CD83/ high-Foxp3 group were significantly shorter compared with those for the other three groups (e, f). p value was determined by log-rank test 
CD25
high Tregs in the regional lymph nodes in patients with gastric cancer are significantly higher than those in control lymph nodes. In the present study, it was interesting that the density of CD83
? DCs in negative lymph nodes in patients with lymph node metastasis was found to be an independent prognostic factor. Although the density of CD83
? DCs in negative lymph nodes in patients with LNM was slightly higher than that in the negative lymph nodes of patients without metastasis, the density of CD83
? DCs in lymph nodes may be an independent prognostic factor in patients with LNM. A low density of CD83
? DCs was correlated with poor prognosis and shorter DFS. This might have resulted from a decreased systemic response in the patients or the possibility of micro-metastasis in the lymph nodes. This is believed to be the first study to show a correlation between the immune response in lymph nodes and the prognosis of gastric cancer. However, further clarification of this correlation, as well as the concept of sentinel lymph nodes, is needed in future studies.
DC maturation is a continuous process that is initiated in the periphery upon antigen encounter and/or by inflammatory cytokines, and is completed during DC-T cell interaction. Numerous factors induce and/or regulate DC maturation, including pathogen-related molecules such as lipopolysaccharide, bacterial DNA, and the balance between pro-and anti-inflammatory signals in the local microenvironment, including tumor necrosis factor, interleukin (IL)-1, IL-6, IL-10, and transforming growth factor (TGF)-b [1] . Cancer cells are known to produce certain cytokines such as IL-6, IL-10, TGF-b, and vascular endothelial growth factor, which do suppress DC maturation.
CD4
? CD25 high Foxp3 ? T cells also secrete IL-10 and TGFb, which both mediate suppression of immune responses in the tumor microenvironment [38] . Recently, Sarrs et al. [39] have found that neuropilin-1, which is expressed by most Tregs, but not naïve T-helper cells, promotes prolonged interaction with immature DCs, which suggests the default suppression of immune responses in the absence of danger signals. Terme et al. [40] have also reported that Tregs control DC/NK cell crosstalk in lymph nodes in the steady state by inhibiting CD4
? self-reactive T cells. In line with these data, it is reasonable to assume that a high density of Foxp3
? Tregs plays an important role, directly or indirectly, in inhibiting the local activation of DCs.
We elucidated two arms of the immune response to cancer: immunoactivation and immunosuppression. For these immune responses, CD83
? DCs and Foxp3 ? Tregs were investigated in primary lesions and regional lymph nodes. Similar trends were found at both sites in association with tumor invasion. For cell-targeted immunotherapy, DCs can be injected directly into the tumor. The elimination of Tregs has been trialed in basic [41, 42] and clinical [43] settings, with some promising results [44] . To further investigate the efficacy of the elimination of Tregs, careful monitoring of the two arms of the immune response will be needed. ? DC level in the negative nodes of metastasispositive cases contributed to both OS (a) and DFS (b). p value was determined by logrank test
